Gilead Sciences Inc. (NASDAQ:GILD) is one of the top large cap value stocks to buy now. On June 8, Gilead Sciences and Merck ...

Gilead Sciences (NasdaqGS:GILD) and Merck reported that their once weekly oral HIV regimen, islatravir and lenacapavir, met ...

Check out the latest Gilead Sciences Inc. (GILD) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

Foster City, California-based Gilead Sciences, Inc. (GILD) discovers, develops, and commercializes medicines in the areas of ...

Looking ahead to 2030, our model projects GILD could trade at an average price of $244.45, with a potential range between $183.34 and $305.57. This represents a potential 101.2% return from today's ...

Biotech bigwig Gilead Sciences, Inc. GILD is scheduled to report fourth-quarter and full-year 2025 results on Feb. 10, after market close. The Zacks Consensus Estimate for fourth-quarter sales and ...

Investors in Gilead Sciences Inc (Symbol: GILD) saw new options begin trading today, for the March 13th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the GILD ...

Shares of Gilead Sciences Inc (NASDAQ: GILD) rallied in early trading on Wednesday after the company reported upbeat fourth-quarter results. Here are the key analyst insights: Check out other analyst ...

Is GILD a good stock to buy? We came across a bullish thesis on Gilead Sciences, Inc. on Trevor Young’s Substack. In this article, we will summarize the bulls’ thesis on GILD. Gilead Sciences, Inc.’s ...